Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis

被引：0

作者：

Cork, M. J. ^{[1
]}

Eichenfield, L. F. ^{[2
,3
]}

Blauvelt, A. ^{[4
]}

Rosmarin, D. ^{[5
]}

Hussain, I. ^{[6
]}

Davis, J. D. ^{[7
]}

Li, M. ^{[8
]}

Zhang, Q. ^{[7
]}

Gadkari, A. ^{[7
]}

Eckert, L. ^{[9
]}

Kamal, M. A. ^{[7
]}

Bansal, A. ^{[7
]}

机构：

[1] Univ Sheffield, Sheffield, S Yorkshire, England

[2] Rady Childrens Hosp, San Diego, CA USA

[3] Univ Calif San Diego, San Diego, CA 92103 USA

[4] Oregon Med Res Ctr, Portland, OR USA

[5] Tufts Med Ctr, Boston, MA USA

[6] Vital Prospects Clin Res Inst, Tulsa, OK USA

[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[8] Sanofi, Bridgewater, NJ USA

[9] Sanofi, Chilly Mazarin, France

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

605

引用

页码：S104 / S104

页数：1

共 50 条

[1] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Zheng, Y.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
[2] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Xu, Xinghua
Zheng, Yi
Zhang, Xin
He, Yanling
Li, Chengxin
[J]. ONCOTARGET, 2017, 8 (65) : 108480 - 108491
[3] Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
Dupuis, Josephine
Tauber, Marie
Mahe, Emmanuel
Jachiet, Marie
Soria, Angele
Tetart, Florence
Puzenat, Eve
Pasteur, Justine
Raison-Peyron, Nadia
Giordano-Labadie, Francoise
Droitcourt, Catherine
Leleu, Camille
Nosbaum, Audrey
Aubert, Helene
Moigne, Marie L. E.
Bernier, Claire
Barbarot, Sebastien
Ezzedine, Khaled
Diaz, Emmanuelle
Hubiche, Thomas
Faiz, Sarah
Azib, Selma
Dezoteux, Frederic
Chosidow, Olivier
Staumont-Salle, Delphine
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
[4] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
Mareschal, Adrien
Puzenat, Eve
Aubin, Francois
[J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
[5] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
Nettis, Eustachio
Patella, Vincenzo
Lombardo, Carla
Detoraki, Aikaterini
Macchia, Luigi
Di Leo, Elisabetta
Carbonara, Monica
Canonica, Giorgio W.
Bonzano, Laura
[J]. ALLERGY, 2020, 75 (10) : 2653 - 2661
[6] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kraft, Magdalena
Worm, Margitta
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
[7] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
Frampton, James E.
Blair, Hannah A.
[J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (04) : 617 - 624
[8] Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis
James E. Frampton
Hannah A. Blair
[J]. American Journal of Clinical Dermatology, 2018, 19 : 617 - 624
[9] Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
Agache, Ioana
Song, Yang
Posso, Margarita
Alonso-Coello, Pablo
Rocha, Claudio
Sola, Ivan
Beltran, Jessica
Akdis, Cezmi
Akdis, Mubeccel
Brockow, Knut
Chivato, Tomas
del Giacco, Stefano
Eiwegger, Thomas
Eyerich, Kilian
Gimenez-Arnau, Ana
Gutermuth, Jan
Guttman-Yassky, Emma
Maurer, Marcus
Ogg, Graham
Ong, Peck Y.
O'Mahony, Liam
Schwarze, Jurgen
Werfel, Thomas
Canelo-Aybar, Carlos
Palomares, Oscar
Jutel, Marek
[J]. ALLERGY, 2021, 76 (01) : 45 - 58
[10] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
Deleuran, M.
Thaci, D.
Beck, L.
Forman, S.
Soong, W.
Hussain, I.
Bissonnette, R.
Bouaziz, J.
Gelfand, J.
Lawrence, S.
Chen, Z.
Akinlade, B.
Gadkari, A.
Eckert, L.
Graham, N.
Ardeleanu, M.
[J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34

← 1 2 3 4 5 →